Name: VERTEX PHARMACEUTICALS INC (VRTX) Stock
Brand: VERTEX PHARMACEUTICALS INC
Rating: 7 (3 reviews)

VRTX Latest News, Press Relases and Analysis

All

Press Releases

7 days ago - By: Chartmill

Vertex Pharmaceuticals Inc (NASDAQ:VRTX) Emerges as a Top Affordable Growth Stock

4 hours ago - By: The Motley Fool - Mentions: VKTX CRSP LLY

Missed Out on Eli Lilly? 2 Healthcare Stocks With Big Catalysts on the Horizon.

a day ago - By: Zacks Investment Research

Vertex Pharmaceuticals Incorporated (VRTX) is Attracting Investor Attention: Here is What You Should Know

2 days ago - By: Benzinga

Is Vertex Pharmaceuticals Inc Gaining or Losing Market Support?

2 days ago - By: The Motley Fool

1 Incredible Reason to Buy Vertex Pharmaceuticals Stock in November

5 days ago - By: Benzinga - Mentions: AZN HUM UNH REPL ...

10 Health Care Stocks With Whale Alerts In Today's Session

8 days ago - By: Zacks Investment Research - Mentions: ALKS CRMD CRSP

CRSP Posts Narrower-Than-Expected Loss in Q3, Sales Miss Estimates

11 days ago - By: Vertex Pharmaceuticals Incorporated

Vertex Presents Updated Phase 1/2 Data From RUBY-3 Study That Continue to Demonstrate Best-in-Class Potential for Povetacicept in Adults with IgA Nephropathy and Primary Membranous Nephropathy at American Society of Nephrology Kidney Week

12 days ago - By: Zacks Investment Research

Vertex Pharmaceuticals Incorporated (VRTX) is Attracting Investor Attention: Here is What You Should Know

14 days ago - By: Zacks Investment Research - Mentions: ANIP NTLA CRSP

VRTX's New Drugs Performance Mixed in Q3: Can Their Sales Improve?

15 days ago - By: Zacks Investment Research - Mentions: ANIP NTLA CRSP

Vertex Q3 Earnings Beat, Stock Down as Casgevy Sales Disappoint

16 days ago - By: Zacks Investment Research

Vertex (VRTX) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates

16 days ago - By: Zacks Investment Research - Mentions: CGEN

Vertex Pharmaceuticals (VRTX) Q3 Earnings and Revenues Top Estimates

16 days ago - By: Investor's Business Daily

Vertex Pharma Dips Despite Quarterly Beat And Slight Guidance Book

16 days ago - By: Bloomberg

Vertex Beats Estimates on Strong Sales of Cystic Fibrosis Drugs

16 days ago - By: Vertex Pharmaceuticals Incorporated

Vertex Reports Third Quarter 2025 Financial Results

16 days ago - By: Zacks Investment Research - Mentions: BEAM NTLA CRSP

Should CRSP Stock Be in Your Portfolio Pre-Q3 Earnings?

19 days ago - By: Zacks Investment Research - Mentions: RIGL ANIP EXAS

Rigel Gears Up to Report Q3 Earnings: Here's What to Expect

21 days ago - By: Zacks Investment Research

Vertex Pharmaceuticals (VRTX) Stock Moves -1.23%: What You Should Know

21 days ago - By: Zacks Investment Research - Mentions: ALNY ZTS EXAS

VERTEX PHARMACEUTICALS INC (VRTX) Stock News

VRTX Latest News, Press Relases and Analysis

Vertex Pharmaceuticals Inc (NASDAQ:VRTX) Emerges as a Top Affordable Growth Stock

Missed Out on Eli Lilly? 2 Healthcare Stocks With Big Catalysts on the Horizon.

Vertex Pharmaceuticals Incorporated (VRTX) is Attracting Investor Attention: Here is What You Should Know

Is Vertex Pharmaceuticals Inc Gaining or Losing Market Support?

1 Incredible Reason to Buy Vertex Pharmaceuticals Stock in November

10 Health Care Stocks With Whale Alerts In Today's Session

CRSP Posts Narrower-Than-Expected Loss in Q3, Sales Miss Estimates

Vertex Presents Updated Phase 1/2 Data From RUBY-3 Study That Continue to Demonstrate Best-in-Class Potential for Povetacicept in Adults with IgA Nephropathy and Primary Membranous Nephropathy at American Society of Nephrology Kidney Week

Vertex Pharmaceuticals Incorporated (VRTX) is Attracting Investor Attention: Here is What You Should Know

VRTX's New Drugs Performance Mixed in Q3: Can Their Sales Improve?

Vertex Q3 Earnings Beat, Stock Down as Casgevy Sales Disappoint

Vertex (VRTX) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates

Vertex Pharmaceuticals (VRTX) Q3 Earnings and Revenues Top Estimates

Vertex Pharma Dips Despite Quarterly Beat And Slight Guidance Book

Vertex Beats Estimates on Strong Sales of Cystic Fibrosis Drugs

Vertex Reports Third Quarter 2025 Financial Results

Should CRSP Stock Be in Your Portfolio Pre-Q3 Earnings?

Rigel Gears Up to Report Q3 Earnings: Here's What to Expect

Vertex Pharmaceuticals (VRTX) Stock Moves -1.23%: What You Should Know

Zoetis Gears Up to Report Q3 Earnings: Here's What to Expect